Skip to main content

Find Clinical Trials

Home
Conditions
Non-alcoholic Steatohepatitis

Clinical trial condition

Non-alcoholic Steatohepatitis

Explore clinical trials studying Non-alcoholic Steatohepatitis. Study availability and eligibility vary by location and protocol.

82 public trials 12 recruiting studies

Refine in advanced search Browse all conditions

Non-alcoholic Steatohepatitis trial results

Completed

Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH)

NCT03812029

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: ENYO PHARMA Investigative site 0424 North Little Rock, Arkansas, United States

ENYO PHARMA Investigative site 0418 Lakewood Rch, Florida, United States

ENYO PHARMA Investigative site 0402 Ocoee, Florida, United States

ENYO PHARMA Investigative site 0420 Orlando, Florida, United States

View all 42 locations

View Trial Details

Completed

Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects

NCT02681055

Conditions: Digestive System Diseases, Dyslipidemias, Fatty Liver, +10 more
Locations: Southern California Research Center Coronado, California, United States

Scripps Research La Jolla, California, United States

Harborview Medical Center Seattle, Washington, United States

View Trial Details

Completed

The Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of HEC88473 in Healthy Subjects

NCT04829123

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: Scientia Clinical Research Sydney, Australia

View Trial Details

Completed

BREATHID Octanoate Breath Test With or Without Methacetin Breath Test for Correlation With Biopsy in NASH

NCT02314026

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States

San Antonio Military Medical Center Forts Sam Houston, Texas, United States

Baylor College of Medicine Houston, Texas, United States

Liver Associates Houston, Texas, United States

View Trial Details

Completed

Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH

NCT05357248

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +4 more
Locations: Arizona Liver Health Chandler, Arizona, United States

Arizona Liver Health Peoria, Arizona, United States

View Trial Details

Completed

Glucagon Resistance in Patients With NAFLD

NCT04042142

Conditions: Digestive System Diseases, Fatty Liver, Glucose Metabolism Disorders, +6 more
Locations: Aarhus University Hospital Aarhus, Danmark, Denmark

View Trial Details

Completed

A Study to Assess the Safety and Tolerability of LB-P6 and LB-P8 in Healthy Participants

NCT05053165

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +12 more
Locations: Cmax Clinical Research Adelaide, Australia

View Trial Details

Completed

Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.

NCT04579874

Conditions: Digestive System Diseases, Fatty Liver, Fibrosis, +11 more
Locations: Henry Ford Health System Detroit, Michigan, United States

St. Louis University St Louis, Missouri, United States

Northwell Health, Inc Manhasset, New York, United States

GCGA Physicians, LLC Cincinnati, Ohio, United States

View Trial Details

Completed

An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis

NCT03656068

Conditions: Compensated Cirrhosis, Digestive System Diseases, Fatty Liver, +8 more
Locations: Pinnacle Clinical Research San Antonio, Texas, United States

View Trial Details

Completed

EUS Guided Core Liver Biopsy and IGB Placement for the Diagnosis and Management of NASH and Obesity

NCT02880189

Conditions: Body Weight, Digestive System Diseases, Fatty Liver, +10 more
Locations: Not specified

View Trial Details